Stéphane Duquerroy
3Patents
0h-index
14Co-inventors
31Inventor score
Filing activity: Jul 23, 2015 → Oct 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12415836B2 | Anti-dengue vaccines and antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US10213413B2 | Antiviral agents directed against respiratory syncytial virus | Chemistry; Metallurgy | 0 | Active |
| US11198706B2 | Anti-dengue vaccines and antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.